On July 3, Health 160 rose 10.38% in regular trading, trading at 10.52 HKD/share, with turnover of 18.881 million HKD.

On the news front, Frost & Sullivan recently published a report certifying Health 160 as the No.1 AI hospital operation service provider in China, ranked by both number of hospital contracts signed and implementation scenarios deployed. As of end of April, the company's 160AI Hospital platform had cumulatively signed 120 public medical institutions, of which 66 are Grade III-A hospitals representing 55%, and 97 are Grade III and above representing 80.8%. Additionally, the company achieved its first-ever positive adjusted net profit earlier this year, with its digital healthcare solutions business delivering a gross margin exceeding 80%, establishing it as the core profit engine.

(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)